Nephropathy Clinical Trial
Official title:
Effect of Intravenous Sodium Chloride on Urinary Biomarkers for Measurement of Sodium- and Water Channel Activity in the Nephron in Healthy Subject an Patients With Chronic Kidney Disease. A Case Control Study
Patients with chronic kidney disease (CKD) have a defect in the tubular reabsorption of
sodium, and therefore the ability to excrete a sodium load is diminished compared to healthy
subjects.
Urinary biomarkers reflects the water- and sodium-channel activity in the kidney and may be
measured after an infusion with hypertonic saline in CKD patients and healthy subjects.
The fractional sodium excretion is elevated as high as 10-20% In patients with chronic
kidney disease (CKD) Changes in the sodium intake results in a slower expansion and/or
reduction in extracellular fluid in CKD patients.
Urinary biomarkers reflects the kidneys transport of sodium and water in the nephron.
Changes in the sodium-and water channel activity is induced by intervention with hypertonic
Saline (3.0%) The change in sodium-and water channel activity is followed by change in
extracellular and intracellular fluid compartments and the plasma concentration of
vasoactive hormones.
The purpose of this study is to investigate the changes in urinary biomarkers (u-NKCC2,
u-ENaC-gamma and u-AQP2), the activity of the sodium-and water channels, the extra- and
intracellular fluid compartments and the plasma concentration of Vasoactive hormones in
patients with CKD and in healthy subjects.
Subjects and patients are examined during one examination day. Four days prior to the
examination day the subjects consume a standardized diet based on the amount of sodium and
calories. On the examination day the subjects receive an infusion with hypertonic saline.
Renal function is measured by renal clearance of 51Cr-EDTA. Urinary biomarkers (u-NKCC2,
u-ENaC-gamma and u-AQP2) are measured to evaluate the activity of sodium channels in the
nephron and changes in fluid compartments are measured by body composition monitor.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Recruiting |
NCT01448889 -
Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy
|
N/A | |
| Active, not recruiting |
NCT05026021 -
Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
|
||
| Completed |
NCT02470247 -
Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients
|
N/A | |
| Recruiting |
NCT05511779 -
Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
|
Phase 2 | |
| Active, not recruiting |
NCT03620773 -
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03584217 -
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
|
Phase 1/Phase 2 | |
| Completed |
NCT03618420 -
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
|
Phase 1/Phase 2 | |
| Completed |
NCT02575092 -
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05839314 -
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
|
Phase 4 | |
| Completed |
NCT01638663 -
Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)
|
Phase 2 | |
| Completed |
NCT01213498 -
The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
|
Phase 2 | |
| Completed |
NCT01208701 -
The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy
|
Phase 2 | |
| Completed |
NCT01214746 -
The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man
|
Phase 2 | |
| Active, not recruiting |
NCT00655330 -
Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
|
N/A | |
| Completed |
NCT00308347 -
A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)
|
Phase 3 | |
| Terminated |
NCT00579995 -
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
|
N/A | |
| Completed |
NCT05986474 -
Development of Synthetic Medical Data Generation Technology to Predict Postoperative Complications
|
||
| Recruiting |
NCT03886714 -
Screening for Fabry Disease in Renal Transplantation
|
||
| Recruiting |
NCT06325059 -
The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases
|
N/A |